The IGF-I Response to Growth Hormone Is Related to Body Mass Index in Short Children with Normal Weight

Hormone Research

Volumn 72, Issue 1, 2009, Pages 10-14

  Roman, Rossana ^a   Iniguez, German ^a   Lammoglia, Juan Javier ^a   Avila, Alejandra ^a   Salazar, Teresa ^a   Cassorla, Fernando ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b NONE   (Chile)

Author keywords

Body mass index; Growth hormone; Insulin like growth factor I; Nutritional status, children

Indexed keywords

CLONIDINE; GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; IMMUNORADIOMETRIC ASSAY; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCHOOL CHILD; SHORT STATURE; SINGLE DRUG DOSE;

BODY COMPOSITION; BODY MASS INDEX; CHILD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE;

EID: 67651091576     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000224335     Document Type: Article

References (27)

1. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG: Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 2007;92:2480-2486.
2. Johannsson G, Rosen T, Bengtsson BA: Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clin Endocrinol (Oxf) 1997;47:571-581.
3. Johannsson G, Bjarnason R, Bramnert M, et al: The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J Clin Endocrinol Metab 1996;81:1575-1581.
4. Hoffman AR, Strasburger CJ, Zagar A, Blum WF, Kehely A, Hartman ML: Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing. J Clin Endocrinol Metab 2004;89:3224-3233.
5. Mauras N, Bishop K, Welch S: Growth hormone action in puberty: effects by gender. Growth Horm IGF Res 2007;17:463-471.
6. Cohen P, Bright GM, Rogol AD, Kappelgaard A-M, Rosenfeld RG: Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab 2002;87:90-98.
7. Drake WM, Coyte D, Camacho-Hubner C, et al: Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 1998;83:3913-3919.
8. Drake WM, Rodriguez-Arnao J, Weaver JU, et al: The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. Clin Endocrinol (Oxf) 2001;54:525-532.
9. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA: Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 1997;82:550-555.
10. 2000 CDC Growth Charts for the United States: Methods and Development. Series Report 11, No 246.
11. Iniguez G, Villavicencio A, Gabler F, Palomino A, Vega M: Effect of nit ric oxide on t he expression of insulin-like growth factors and the insulin-like growth factor binding proteins throughout the lifespan of the human corpus luteum. Reproduction 2001;122:865-873.
12. Brown JJ, Warne GL: Growth in precocious puberty. India n J Pediatr 2006;73:81-88.
13. Nam SY, Lee EJ, Kim KR, et al: Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 1997;21:355-359.
14. Bou hours-Nouet N, Gatelais F, Boux de Casson F, Rouleau S, Coutant R: The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature. J Clin Endocrinol Metab 2007;92:629-635.
15. Copeland KC, Underwood LE, Van Wyk JJ: Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chro-matographic profiles. J Clin Endocrinol Metab 1980;50:690-697.
16. Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP, Rosenfeld RG: The IGF-I generation test revisited: a marker of GH sensitivity. J Clin Endocrinol Metab 2001;86:5176-5183.
17. Blair JC, Savage MO: The GH-IGF-I axis in children with idiopathic short stature. Trends Endocrinol Metab 2002;13:325-330.
18. Drake WM, Coyte D, Camacho-Hubner C, et al: Optimizing growth hormone replacement therapy by dose titration in hypopitu-itary adults. J Clin Endocrinol Metab 1998;83:3913-3919.
19. Rudman D, Kutner MH, Blackston RD, Cushman RA, Bain RP, Patterson JH: Children with normal-variant short stature: treatment with human growth hormone for six months. N Engl J Med 1981;305:123-131.
20. Kemp SF, Rosenfeld RG, Liu F, Gaspich S, Hintz RL: Acute somatomedin response to growth hormone: radioreceptor assay versus radioimmunoassay. J Clin Endocrinol Metab 1981;52:616-621.
21. Rosenfeld RG, Kemp SF, Hintz RL: Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. J Clin Endocrinol Metab 1981;53:611-617.
22. Misra M, Miller KK, Cord J, et al: Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 2007;92:2046-2052.
23. Woelfle JF, Harz K, Roth C: Modulation of circulating IGF-I and IGFBP-3 levels by hormonal regulators of energy homeostasis in obese children. Exp Clin Endocrinol Diabetes 2007;115:17-23.
24. Jorgensen JO, Blum WF, Moller N, Ranke MB, Christiansen JS: Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. J Clin Endocrinol Metab 1991;72:582-587.
25. Salerno M, Balestrieri B, Matrecano E, et al: Abnormal GH receptor signaling in children with idiopathic short stature. J Clin Endocrinol Metab 2001;86:3882-3888.
26. Schwarze CP, Wollmann HA, Binder G, Ranke MB: Short-term increments of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 predict the growth response to growth hormone (GH) therapy in GH-sensitive children. Acta Paediatr 1999;88(suppl):200-208.
27. Kemp SF, Rosenfeld RG, Liu F, Gaspich S, Hintz RL: Acute somatomedin response to growth hormone: radioreceptor assay versus radioimmunoassay. J Clin Endocrinol Metab 1981;52:616-621.